Malhi GS - Search Results

1

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. Dodd S, et al. Among authors: malhi gs. Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901. Expert Opin Biol Ther. 2008. PMID: 18990082 Review.

2

Pharmacotherapy to limit weight gain caused by antipsychotic use.

Malhi GS, Mitchell PB. Malhi GS, et al. Expert Opin Pharmacother. 2003 Oct;4(10):1679-86. doi: 10.1517/14656566.4.10.1679. Expert Opin Pharmacother. 2003. PMID: 14521478 Review.

3

To combine or not to combine? A literature review of antidepressant combination therapy.

Dodd S, Horgan D, Malhi GS, Berk M. Dodd S, et al. Among authors: malhi gs. J Affect Disord. 2005 Dec;89(1-3):1-11. doi: 10.1016/j.jad.2005.08.012. Epub 2005 Sep 16. J Affect Disord. 2005. PMID: 16169088

4

Emerging drugs for bipolar disorder.

Mitchell PB, Malhi GS. Mitchell PB, et al. Among authors: malhi gs. Expert Opin Emerg Drugs. 2006 Nov;11(4):621-34. doi: 10.1517/14728214.11.4.621. Expert Opin Emerg Drugs. 2006. PMID: 17064222 Review.

5

The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.

Berk M, Malhi GS, Cahill C, Carman AC, Hadzi-Pavlovic D, Hawkins MT, Tohen M, Mitchell PB. Berk M, et al. Among authors: malhi gs. Bipolar Disord. 2007 Sep;9(6):571-9. doi: 10.1111/j.1399-5618.2007.00536.x. Bipolar Disord. 2007. PMID: 17845271

6

Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives.

Berk M, Malhi GS, Hallam K, Gama CS, Dodd S, Andreazza AC, Frey BN, Kapczinski F. Berk M, et al. Among authors: malhi gs. J Affect Disord. 2009 Apr;114(1-3):1-13. doi: 10.1016/j.jad.2008.08.011. Epub 2008 Sep 26. J Affect Disord. 2009. PMID: 18819715 Review.

7

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting.

Berk M, Jeavons S, Dean OM, Dodd S, Moss K, Gama CS, Malhi GS. Berk M, et al. Among authors: malhi gs. CNS Spectr. 2009 Jul;14(7):357-60. doi: 10.1017/s1092852900023002. CNS Spectr. 2009. PMID: 19773711

8

Evidence and implications for early intervention in bipolar disorder.

Berk M, Hallam K, Malhi GS, Henry L, Hasty M, Macneil C, Yucel M, Pantelis C, Murphy B, Vieta E, Dodd S, McGorry PD. Berk M, et al. Among authors: malhi gs. J Ment Health. 2010 Apr;19(2):113-26. doi: 10.3109/09638230903469111. J Ment Health. 2010. PMID: 20433320 Review.

9

Health-related quality of life and functioning in bipolar disorder: the impact of pharmacotherapy.

Berk M, Hallam K, Lucas N, Kader L, Macneil C, Hasty M, Dodd S, Malhi G, Conus P. Berk M, et al. Expert Rev Pharmacoecon Outcomes Res. 2006 Oct;6(5):509-23. doi: 10.1586/14737167.6.5.509. Expert Rev Pharmacoecon Outcomes Res. 2006. PMID: 20528499

10

From neuroprogression to neuroprotection: implications for clinical care.

Berk M, Conus P, Kapczinski F, Andreazza AC, Yücel M, Wood SJ, Pantelis C, Malhi GS, Dodd S, Bechdolf A, Amminger GP, Hickie IB, McGorry PD. Berk M, et al. Among authors: malhi gs. Med J Aust. 2010 Aug 16;193(S4):S36-40. Med J Aust. 2010. PMID: 20712560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results